Home  >  Products  >  SSX8 (synovial sarcoma, X breakpoint 8) Blocking Peptide (100ug)
SSX8 (synovial sarcoma, X breakpoint 8) Blocking Peptide (100ug)

SSX8 (synovial sarcoma, X breakpoint 8) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SSX8 antibody (Catalogue #: ARP51719_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP51719
Size: 100 ug
Weight: 17kDa
Gene: 280659
Format: Lyophilized powder
Target: SSX8 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X;18) translocation characteristically found in all synovial sarcomas.
See Full Product Listings >